M L Rots1,2, M J A M van Putten3,4, C W E Hoedemaekers5, J Horn6. 1. Department of Intensive Care Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. marjolijnrots@gmail.com. 2. Clinical Neurophysiology Group, MIRA - Institute for Biomedical Technology and Technical Medicine, University of Twente, Hallenweg 15, 7522 NB, Enschede, The Netherlands. marjolijnrots@gmail.com. 3. Clinical Neurophysiology Group, MIRA - Institute for Biomedical Technology and Technical Medicine, University of Twente, Hallenweg 15, 7522 NB, Enschede, The Netherlands. 4. Department of Neurology and Clinical Neurophysiology, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands. 5. Department of Intensive Care Medicine, Radboud University Nijmegen Medical Center, Geert Grooteplein-Zuid 10, 6525 GA, Nijmegen, The Netherlands. 6. Department of Intensive Care Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Abstract
INTRODUCTION: Early identification of delayed cerebral ischemia (DCI) in patients with aneurysmal subarachnoid hemorrhage (aSAH) is a major challenge. The aim of this study was to investigate whether quantitative EEG (qEEG) features can detect DCI prior to clinical or radiographic findings. METHODS: A prospective cohort study was performed in aSAH patients in whom continuous EEG (cEEG) was recorded. We studied 12 qEEG features. We compared the time point at which qEEG changed with the time point that clinical deterioration occurred or new ischemia was noted on CT scan. RESULTS: Twenty aSAH patients were included of whom 11 developed DCI. The alpha/delta ratio (ADR) was the most promising feature that showed a significant difference in change over time in the DCI group (median -62% with IQR -87 to -39%) compared to the control group (median +27% with IQR -32 to +104%, p = 0.013). Based on the ROC curve, a threshold was chosen for a combined measure of ADR and alpha variability (AUC: 91.7, 95% CI 74.2-100). The median time that elapsed between change of qEEG and clinical DCI diagnosis was seven hours (IQR -11-25). Delay between qEEG and CT scan changes was 44 h (median, IQR 14-117). CONCLUSION: In this study, ADR and alpha variability could detect DCI development before ischemic changes on CT scan was apparent and before clinical deterioration was noted. Implementation of cEEG in aSAH patients can probably improve early detection of DCI.
INTRODUCTION: Early identification of delayed cerebral ischemia (DCI) in patients with aneurysmal subarachnoid hemorrhage (aSAH) is a major challenge. The aim of this study was to investigate whether quantitative EEG (qEEG) features can detect DCI prior to clinical or radiographic findings. METHODS: A prospective cohort study was performed in aSAH patients in whom continuous EEG (cEEG) was recorded. We studied 12 qEEG features. We compared the time point at which qEEG changed with the time point that clinical deterioration occurred or new ischemia was noted on CT scan. RESULTS: Twenty aSAH patients were included of whom 11 developed DCI. The alpha/delta ratio (ADR) was the most promising feature that showed a significant difference in change over time in the DCI group (median -62% with IQR -87 to -39%) compared to the control group (median +27% with IQR -32 to +104%, p = 0.013). Based on the ROC curve, a threshold was chosen for a combined measure of ADR and alpha variability (AUC: 91.7, 95% CI 74.2-100). The median time that elapsed between change of qEEG and clinical DCI diagnosis was seven hours (IQR -11-25). Delay between qEEG and CT scan changes was 44 h (median, IQR 14-117). CONCLUSION: In this study, ADR and alpha variability could detect DCI development before ischemic changes on CT scan was apparent and before clinical deterioration was noted. Implementation of cEEG in aSAH patients can probably improve early detection of DCI.
Authors: Jan Claassen; Lawrence J Hirsch; Jennifer A Frontera; Andres Fernandez; Michael Schmidt; Gregory Kapinos; John Wittman; E Sander Connolly; Ronald G Emerson; Stephan A Mayer Journal: Neurocrit Care Date: 2006 Impact factor: 3.210
Authors: Jose Leon-Carrion; Juan Francisco Martin-Rodriguez; Jesus Damas-Lopez; Juan Manuel Barroso y Martin; Maria Rosario Dominguez-Morales Journal: Clin Neurophysiol Date: 2009-04-23 Impact factor: 3.708
Authors: S Gollwitzer; T Groemer; S Rampp; M Hagge; D Olmes; H B Huttner; S Schwab; D Madžar; R Hopfengaertner; H M Hamer Journal: Clin Neurophysiol Date: 2014-11-14 Impact factor: 3.708
Authors: Jan Claassen; Lawrence J Hirsch; Kurt T Kreiter; Evelyn Y Du; E Sander Connolly; Ronald G Emerson; Stephan A Mayer Journal: Clin Neurophysiol Date: 2004-12 Impact factor: 3.708
Authors: Eric S Rosenthal; Siddharth Biswal; Sahar F Zafar; Kathryn L O'Connor; Sophia Bechek; Apeksha V Shenoy; Emily J Boyle; Mouhsin M Shafi; Emily J Gilmore; Brandon P Foreman; Nicolas Gaspard; Thabele M Leslie-Mazwi; Jonathan Rosand; Daniel B Hoch; Cenk Ayata; Sydney S Cash; Andrew J Cole; Aman B Patel; M Brandon Westover Journal: Ann Neurol Date: 2018-05-16 Impact factor: 10.422
Authors: Hsin Yi Chen; Jonathan Elmer; Sahar F Zafar; Manohar Ghanta; Valdery Moura Junior; Eric S Rosenthal; Emily J Gilmore; Lawrence J Hirsch; Hitten P Zaveri; Kevin N Sheth; Nils H Petersen; M Brandon Westover; Jennifer A Kim Journal: Neurology Date: 2021-11-29 Impact factor: 9.910
Authors: Ayham Alkhachroum; Brian Appavu; Benjamin Rohaut; Jan Claassen; Satoshi Egawa; Brandon Foreman; Nicolas Gaspard; Emily J Gilmore; Lawrence J Hirsch; Pedro Kurtz; Virginie Lambrecq; Julie Kromm; Paul Vespa; Sahar F Zafar Journal: Intensive Care Med Date: 2022-08-23 Impact factor: 41.787
Authors: Hae Young Baang; Hsin Yi Chen; Alison L Herman; Emily J Gilmore; Lawrence J Hirsch; Kevin N Sheth; Nils H Petersen; Sahar F Zafar; Eric S Rosenthal; M Brandon Westover; Jennifer A Kim Journal: J Clin Neurophysiol Date: 2022-03-01 Impact factor: 2.590
Authors: W Taylor Kimberly; Eric S Rosenthal; India A Lissak; Sahar F Zafar; M Brandon Westover; Riana L Schleicher; Jennifer A Kim; Thabele Leslie-Mazwi; Christopher J Stapleton; Aman B Patel Journal: Stroke Date: 2020-03-11 Impact factor: 7.914